-
公开(公告)号：US09550764B2
公开(公告)日：2017-01-24
申请号：US14421503
申请日：2013-08-22
Inventor： Keith Jones , Matthew David Cheeseman , Spyridon Linardopoulos , Amir Faisal , Olivier Remi Barbeau , Andrew Kalusa
IPC: C07D417/10 , C07D417/14 , C07D417/04 , C07D413/04
CPC classification number: C07D417/14 , C07D413/04 , C07D413/10 , C07D417/04 , C07D417/10
Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts, hydrates and solvates thereof for use in the treatment of cancer:
Abstract translation: 本发明提供了用于治疗癌症的式（I）化合物及其药学上可接受的盐，水合物和溶剂合物：
-
公开(公告)号：US20150232462A1
公开(公告)日：2015-08-20
申请号：US14421503
申请日：2013-08-22
Inventor： Keith Jones , Matthew David Cheeseman , Spyridon Linardopoulos , Amir Faisal , Olivier Remi Barbeau , Andrew Kalusa
IPC: C07D417/14 , C07D413/04 , C07D417/04
CPC classification number: C07D417/14 , C07D413/04 , C07D413/10 , C07D417/04 , C07D417/10
Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts, hydrates and solvates thereof for use in the treatment of cancer:
Abstract translation: 本发明提供了用于治疗癌症的式（I）化合物及其药学上可接受的盐，水合物和溶剂合物：
-
Search Results
2
records
(took 0.019 seconds)
